BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 15201353)

  • 1. The generic 15D instrument is valid and feasible for measuring health related quality of life in Parkinson's disease.
    Haapaniemi TH; Sotaniemi KA; Sintonen H; Taimela E
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):976-83. PubMed ID: 15201353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease.
    Schrag A; Selai C; Jahanshahi M; Quinn NP
    J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):67-73. PubMed ID: 10864606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in Parkinson's disease: a cross-sectional study focusing on non-motor symptoms.
    Kadastik-Eerme L; Rosenthal M; Paju T; Muldmaa M; Taba P
    Health Qual Life Outcomes; 2015 Jun; 13():83. PubMed ID: 26088201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Key Determinants to Quality of Life in Parkinson's Disease Patients: Results from the Parkinson's Disease Biomarker Program (PDBP).
    He L; Lee EY; Sterling NW; Kong L; Lewis MM; Du G; Eslinger PJ; Huang X
    J Parkinsons Dis; 2016 May; 6(3):523-32. PubMed ID: 27258700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between objectively measured physical activity, depression, cognition, and health-related quality of life in Parkinson's disease.
    van Uem JMT; Cerff B; Kampmeyer M; Prinzen J; Zuidema M; Hobert MA; Gräber S; Berg D; Maetzler W; Liepelt-Scarfone I
    Parkinsonism Relat Disord; 2018 Mar; 48():74-81. PubMed ID: 29307560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease.
    Lezcano E; Gómez-Esteban JC; Tijero B; Bilbao G; Lambarri I; Rodriguez O; Villoria R; Dolado A; Berganzo K; Molano A; de Gopegui ER; Pomposo I; Gabilondo I; Zarranz JJ
    J Neurol; 2016 May; 263(5):895-905. PubMed ID: 26964542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in inflammatory bowel disease measured with the generic 15D instrument.
    Haapamäki J; Roine RP; Sintonen H; Turunen U; Färkkilä MA; Arkkila PE
    Qual Life Res; 2010 Aug; 19(6):919-28. PubMed ID: 20361263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and Parkinson's disease: Philippine translation and validation of the Parkinson's disease questionnaire.
    Suratos CTR; Saranza GRM; Sumalapao DEP; Jamora RDG
    J Clin Neurosci; 2018 Aug; 54():156-160. PubMed ID: 29907384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life and its determinants in Parkinson's disease: results of an Italian cohort study.
    Winter Y; von Campenhausen S; Arend M; Longo K; Boetzel K; Eggert K; Oertel WH; Dodel R; Barone P
    Parkinsonism Relat Disord; 2011 May; 17(4):265-9. PubMed ID: 21310647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life scale in Parkinson's disease PDQ-39 - (Brazilian Portuguese version) to assess patients with and without levodopa motor fluctuation.
    Souza RG; Borges V; Silva SM; Ferraz HB
    Arq Neuropsiquiatr; 2007 Sep; 65(3B):787-91. PubMed ID: 17952281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.
    Martínez-Martín P; Rodríguez-Blázquez C; Forjaz MJ; Alvarez-Sánchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martínez-Castrillo JC; Mendoza-Rodríguez A; Moore HP; Rodríguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG
    Eur J Neurol; 2014 Mar; 21(3):519-24. PubMed ID: 24447695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in Parkinson disease: correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veterans.
    Kleiner-Fisman G; Stern MB; Fisman DN
    Health Qual Life Outcomes; 2010 Aug; 8():91. PubMed ID: 20799993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the relationship between non-motor symptoms and health-related quality of life in Parkinson's disease: a retrospective observational cohort study.
    Ueno T; Kon T; Haga R; Nishijima H; Arai A; Tomiyama M
    Neurol Sci; 2020 Oct; 41(10):2867-2873. PubMed ID: 32328832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study.
    Reuther M; Spottke EA; Klotsche J; Riedel O; Peter H; Berger K; Athen O; Köhne-Volland R; Dodel RC
    Parkinsonism Relat Disord; 2007 Mar; 13(2):108-14. PubMed ID: 17055326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal metric properties of disability rating scales for Parkinson's disease.
    Martinez-Martin P; Prieto L; Forjaz MJ
    Value Health; 2006; 9(6):386-93. PubMed ID: 17076869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported outcomes in coronary artery disease: the relationship between the standard, disease-specific set by the International Consortium for Health Outcomes Measurement (ICHOM) and the generic health-related quality of life instrument 15D.
    Lappalainen L; Stenvall H; Lavikainen P; Miettinen H; Martikainen J; Sintonen H; Tolppanen AM; Roine RP; Hartikainen J
    Health Qual Life Outcomes; 2021 Aug; 19(1):206. PubMed ID: 34454528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social and clinical determinants of quality of life in Parkinson's disease in Austria: a cohort study.
    Winter Y; von Campenhausen S; Gasser J; Seppi K; Reese JP; Pfeiffer KP; Bötzel K; Oertel WH; Dodel R; Poewe W
    J Neurol; 2010 Apr; 257(4):638-45. PubMed ID: 19946784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study.
    Winter Y; von Campenhausen S; Popov G; Reese JP; Balzer-Geldsetzer M; Kukshina A; Zhukova TV; Bertschi N; Bötzel K; Gusev E; Oertel WH; Dodel R; Guekht A
    Parkinsonism Relat Disord; 2010 May; 16(4):243-8. PubMed ID: 20022549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous Determinants of Quality of Life in Different Phenotypes of Parkinson's Disease.
    Fereshtehnejad SM; Shafieesabet M; Farhadi F; Hadizadeh H; Rahmani A; Naderi N; Khaefpanah D; Shahidi GA; Delbari A; Lökk J
    PLoS One; 2015; 10(9):e0137081. PubMed ID: 26335773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.